Canada retaliates, places tariffs on $107 billion of US imports

NasdaqGM - Nasdaq Real Time Price USD

Aspire Biopharma Holdings, Inc. (ASBP)

1.0100

-0.4900

(-32.67%)

At close: March 3 at 4:00:03 PM EST

1.0201

+0.01

+(1.00%)

After hours: 7:58:56 PM EST

Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement

New product expected to set a new standard for potency and performance in the estimated $20 billon pre-workout market Desert Stream Inc., a well-established nutritional and supplement manufacturer of caffeine-based products, engaged for sourcing of ...

ACCESS Newswire 18 hours ago

ASBP
-32.67%
ASBPW
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete Test results support the next development step with Phase 1clinical trial expected to commence in April Provides Summary of Expected ...

ACCESS Newswire 6 days ago

ASBP
-32.67%
ASBPW
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology (Nasdaq:ASBP)(Nasdaq:ASBPW), today announced ...

ACCESS Newswire 11 days ago

ASBP
-32.67%
ASBPW
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, nutraceuticals, and supplements Aspire has multiple product ...

ACCESS Newswire 11 days ago

ASBP
-32.67%
PWUP

PWUPU

Performance Overview

Return	ASBP	S&P 500
YTD	-91.22%	-0.54%
1-Year	-90.83%	+13.87%
3-Year	-89.87%	+34.06%